ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes

por Delia, D, Mizutani, S, Panigone, S, Tagliabue, E, Fontanella, E, Asada, M, Yamada, T, Taya, Y, Prudente, S, Saviozzi, S, Frati, L, Pierotti, M A, Chessa, L
Publicado 2000

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature

por Pelgrims, J, Vos, F De, Brande, J Van den, Schrijvers, D, Prové, A, Vermorken, J B
Publicado 2000

Gene rearrangement and Chernobyl related thyroid cancers

por Santoro, M, Thomas, G A, Vecchio, G, Williams, G H, Fusco, A, Chiappetta, G, Pozcharskaya, V, Bogdanova, T I, Demidchik, E P, Cherstvoy, E D, Voscoboinik, L, Tronko, N D, Carss, A, Bunnell, H, Tonnachera, M, Parma, J, Dumont, J E, Keller, G, Höfler, H, Williams, E D
Publicado 2000

Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women

por Daidone, M G, Luisi, A, Martelli, G, Benini, E, Veneroni, S, Tomasic, G, De Palo, G, Silvestrini, R
Publicado 2000

Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models

por Lee, O H, Bae, S K, Bae, M H, Lee, Y M, Moon, E J, Cha, H J, Kwon, Y G, Kim, K W
Publicado 2000

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma

por Beale, P J, Rogers, P, Boxall, F, Sharp, S Y, Kelland, L R
Publicado 2000

APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis

por Ficari, F, Cama, A, Valanzano, R, Curia, M C, Palmirotta, R, Aceto, G, Esposito, D L, Crognale, S, Lombardi, A, Messerini, L, Mariani-Costantini, R, Tonelli, F, Battista, P
Publicado 2000

Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity

por Harding, C, Osundeko, O, Tetlow, L, Faragher, E B, Howell, A, Bundred, N J
Publicado 2000

Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer

por Kato, T, Kimura, T, Miyakawa, R, Fujii, A, Yamamoto, K, Kameoka, S, Nishikawa, T, Kasajima, T
Publicado 2000

Identification of a founder BRCA2 mutation in Sardinia

por Pisano, M, Cossu, A, Persico, I, Palmieri, G, Angius, A, Casu, G, Palomba, G, Sarobba, M G, Rocca, P C Ossu, Dedola, M F, Olmeo, N, Pasca, A, Budroni, M, Marras, V, Pisano, A, Farris, A, Massarelli, G, Pirastu, M, Tanda, Francesco
Publicado 2000

Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors

por Nosarti, C, Crayford, T, Roberts, J V, Elias, E, McKenzie, K, David, A S
Publicado 2000

p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line

por Badie, C, Bourhis, J, Sobczak-Thépot, J, Haddada, H, Chiron, M, Janicot, M, Janot, F, Tursz, T, Vassal, G
Publicado 2000

Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent

por Seker, H, Bertram, B, Bürkle, A, Kaina, B, Pohl, J, Koepsell, H, Wießler, M
Publicado 2000

Early evaluation of tumour metabolic response using [(18)F]fluorodeoxyglucose and positron emission tomography:a pilot study following the phase II chemotherapy schedule for temozo...

por Brock, C S, Young, H, O'Reilly, S M, Matthews, J, Osman, S, Evans, H, Newlands, E S, Price, P M
Publicado 2000

17 β -Hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters

por Suzuki, T, Moriya, T, Ariga, N, Kaneko, C, Kanazawa, M, Sasano, H
Publicado 2000

Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation

por Claeskens, A, Ongenae, N, Neefs, J M, Cheyns, P, Kaijen, P, Cools, M, Kutoh, E
Publicado 2000

Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes

por Allal, A S, Bieri, S, Pelloni, A, Spataro, V, Anchisi, S, Ambrosetti, P, Sprangers, M A G, Kurtz, J M, Gertsch, P
Publicado 2000

Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas

por Iolascon, A, Giordani, L, Borriello, A, Carbone, R, Izzo, A, Tonini, G P, Gambini, C, Ragione, F Della
Publicado 2000

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

por Windbichler, G H, Hausmaninger, H, Stummvoll, W, Graf, A H, Kainz, C, Lahodny, J, Denison, U, Müller-Holzner, E, Marth, C
Publicado 2000

Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features

por Geradts, J, Fong, K M, Zimmerman, P V, Minna, J D
Publicado 2000